Abiopharma

🔍 Mackey Ashley M (Executive)

Company: Sanara MedTech Inc. (SMTI)

Report Date: 2026-03-22

Detailed Transactions and Holdings:

• Sold 2,804 shares of Common Stock (Direct)
  Date: 2026-03-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,067.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.